Star Combo Pharma Stock Current Valuation
| S66 Stock | 0.13 0.02 13.33% |
Valuation analysis of Star Combo Pharma helps investors to measure Star Combo's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Star Combo's Cash And Short Term Investments are comparatively stable compared to the past year. Cash And Equivalents is likely to gain to about 7.3 M in 2025, whereas Cash is likely to drop slightly above 2.4 M in 2025. Fundamental drivers impacting Star Combo's valuation include:
Price Book 0.608 | Enterprise Value 16.9 M | Enterprise Value Ebitda 6.0764 | Price Sales 0.6749 | Trailing PE 15 |
Overvalued
Today
Please note that Star Combo's price fluctuation is out of control at this time. Calculation of the real value of Star Combo Pharma is based on 3 months time horizon. Increasing Star Combo's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Star Combo's intrinsic value may or may not be the same as its current market price of 0.13, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.13 | Real 0.12 | Hype 0.15 |
The intrinsic value of Star Combo's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Star Combo's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Star Combo Pharma helps investors to forecast how Star stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Star Combo more accurately as focusing exclusively on Star Combo's fundamentals will not take into account other important factors: Star Combo Pharma Company Current Valuation Analysis
Star Combo's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Star Combo Current Valuation | 16.93 M |
Most of Star Combo's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Star Combo Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Star Combo Pharma has a Current Valuation of 16.93 M. This is 99.91% lower than that of the Personal Care Products sector and 99.95% lower than that of the Consumer Staples industry. The current valuation for all Australia stocks is 99.9% higher than that of the company.
Star Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Star Combo's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Star Combo could also be used in its relative valuation, which is a method of valuing Star Combo by comparing valuation metrics of similar companies.Star Combo is currently under evaluation in current valuation category among its peers.
Star Fundamentals
| Return On Equity | 0.0224 | ||||
| Return On Asset | 0.0136 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 16.93 M | ||||
| Shares Outstanding | 135.08 M | ||||
| Shares Owned By Insiders | 93.57 % | ||||
| Price To Book | 0.61 X | ||||
| Price To Sales | 0.67 X | ||||
| Revenue | 26.02 M | ||||
| Gross Profit | 4.82 M | ||||
| EBITDA | 2.79 M | ||||
| Net Income | 747.33 K | ||||
| Cash And Equivalents | 6.5 M | ||||
| Total Debt | 4.03 M | ||||
| Book Value Per Share | 0.25 X | ||||
| Cash Flow From Operations | (316.45 K) | ||||
| Earnings Per Share | 0.01 X | ||||
| Beta | 0.45 | ||||
| Market Capitalization | 20.26 M | ||||
| Total Asset | 42.82 M | ||||
| Retained Earnings | (10.08 M) | ||||
| Working Capital | 13.77 M | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 42.82 M | ||||
| Last Dividend Paid | 0.004 |
About Star Combo Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Star Combo Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Star Combo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Star Combo Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Star Stock Analysis
When running Star Combo's price analysis, check to measure Star Combo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Star Combo is operating at the current time. Most of Star Combo's value examination focuses on studying past and present price action to predict the probability of Star Combo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Star Combo's price. Additionally, you may evaluate how the addition of Star Combo to your portfolios can decrease your overall portfolio volatility.